Pharming Group (Netherlands) Investor Sentiment

PHARM Stock  EUR 0.83  0.02  2.35%   
About 61% of Pharming Group's investor base is looking to short. The analysis of current outlook of investing in Pharming Group NV suggests that many traders are alarmed regarding Pharming Group's prospects. The current market sentiment, together with Pharming Group's historical and current headlines, can help investors time the market. In addition, many technical investors use Pharming Group NV stock news signals to limit their universe of possible portfolio assets.
  
over three months ago at news.google.com         
Pharming Group Sees Large Volume Increase - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Pharming Group Shares Gap Down to 8.27 - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Pharming Group Sets New 52-Week Low at 7.67 - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Pharming Group Stock Price Down 4.7 percent - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Pharming Group Shares Gap Down to 8.44 - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Pharming Group Sees Unusually-High Trading Volume - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Pharming Group Shareholders Approve Key Proposals - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
Pharming Group Sees Strong Trading Volume - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Equities Analysts Set Expectations for Pharming Groups FY2025 Earnings - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Pharming Group N.V. Q1 2024 Earnings Call Transcript - Seeking Alpha
Google News at Macroaxis
over six months ago at news.google.com         
Pharming Group Expected to Earn Q3 2024 Earnings of 0.01 Per Share - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Pharming Group Sees Strong Trading Volume - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Pharming Group Shares Down 8.8 percent - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Pharming Groups Strategic Financial Maneuver - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
Pharming Group Shares Gap Down to 10.00 - MarketBeat
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Pharming Group that are available to investors today. That information is available publicly through Pharming media outlets and privately through word of mouth or via Pharming internal channels. However, regardless of the origin, that massive amount of Pharming data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pharming Group news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pharming Group relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pharming Group's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pharming Group alpha.

Pharming Group Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Pharming Stock analysis

When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Content Syndication
Quickly integrate customizable finance content to your own investment portal